1150311-30-0Relevant articles and documents
Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands
Lee, Suk Ho,Seo, Hee Jeong,Kim, Min Ju,Kang, Suk Youn,Song, Kwang-Seop,Lee, Sung-Han,Jung, Myung Eun,Kim, Jeongmin,Lee, Jinhwa
scheme or table, p. 1899 - 1902 (2009/11/30)
Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of